Compare ELUT & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELUT | RMCO |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.5M | 37.9M |
| IPO Year | 2020 | 2021 |
| Metric | ELUT | RMCO |
|---|---|---|
| Price | $0.84 | $3.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 52.0K | 12.8K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | ★ 146.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,293,000.00 | $4,949,916.00 |
| Revenue This Year | N/A | $209.10 |
| Revenue Next Year | $10.83 | $133.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 513.30 |
| 52 Week Low | $0.50 | $1.53 |
| 52 Week High | $2.50 | $5.00 |
| Indicator | ELUT | RMCO |
|---|---|---|
| Relative Strength Index (RSI) | 33.79 | 73.65 |
| Support Level | $0.51 | $2.72 |
| Resistance Level | $1.13 | $3.82 |
| Average True Range (ATR) | 0.07 | 0.20 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 16.70 | 85.00 |
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.